Is Aphria (TSX:APHA) Stock a Buy After 2 Consecutive Profitable Quarters?

Aphria (TSX:APHA)(NYSE:APHA) just knocked it out of the park again. Yesterday, the company released its Q1 earnings, which showed an 848% year-over-year revenue-growth rate along with positive net and operating income. This isn’t the first time a large cannabis producer posted huge growth and profits in the same quarter. However, it’s the first time that any of the “big three”…

Read More

Buying the Dope Dip: Which Cannabis Stock Is Worth it?

It’s been an exciting two years for investors who’d picked up pot before it got hot. For those who got in on the ground floor, you’re likely even now sitting back and feeling pretty proud of yourself for buying up a few big names before they soared. With prices reaching fever pitch back in the summer of 2018 and again…

Read More

Alliqua BioMedical, Inc. (NASDAQ: ALQA) Skyrockets 168% After Announcing Plans to Spin-Off and Merger Contract Manufacturing Business With TO Pharmaceuticals, LLC

Alliqua BioMedical, Inc. (NASDAQ: ALQA) operates as a custom manufacturer within the medical device, cosmetics, OTC markets. Shares of the medical manufacturer are skyrocketing 168.08%, through early trading on Wednesday, November 28, 2018. Over the past three months, Alliqua BioMedical, Inc. has seen average daily volume of 13,278 shares. However, volume of 15.06 million shares or dollar volume of $59.94…

Read More